Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy
Ya Zhang, Zelin Hu, Jifa Zhang, Changyu Ren, Yuxi Wang
Topics & Concepts
Indoleamine 2,3-dioxygenaseKynurenineChemistryCancer immunotherapyKynurenine pathwayImmunotherapyTumor microenvironmentCancerPharmacophorePharmacologyComputational biologyCancer researchMedicineTryptophanBiochemistryBiologyInternal medicineAmino acidTryptophan and brain disordersHistone Deacetylase Inhibitors ResearchEpigenetics and DNA Methylation